Ocular Therapeutix
OCUL
OCUL
179 hedge funds and large institutions have $1.14B invested in Ocular Therapeutix in 2024 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 63 increasing their positions, 36 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
7% more funds holding
Funds holding: 168 → 179 (+11)
4.63% less ownership
Funds ownership: 89.76% → 85.13% (-4.6%)
6% less capital invested
Capital invested by funds: $1.22B → $1.14B (-$76.8M)
Holders
179
Holding in Top 10
11
Calls
$5.19M
Puts
$2.74M
Top Buyers
| 1 | +$7.65M | |
| 2 | +$4.2M | |
| 3 | +$3.82M | |
| 4 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$2.38M |
| 5 |
RA
Rosalind Advisors
Toronto,
Ontario, Canada
|
+$2.08M |
Top Sellers
| 1 | -$24.6M | |
| 2 | -$19.5M | |
| 3 | -$19.2M | |
| 4 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$5.83M |
| 5 |
SR
Summer Road
West Palm Beach,
Florida
|
-$4.52M |